6-alpha-ethylchenodeoxycholic acid | |
---|---|
Trade Name | |
Orphan Indication | Primary sclerosing cholangitis |
USA Market Approval | USA |
USA Designation Date | 2008-04-09 00:00:00 |
Sponsor | Intercept Pharmaceuticals, Inc.;18 Desbrosses Street;New York, New York, 10013 |